Pyrotinib Plus Chemotherapy May Improve Outcomes in Patients With Pretreated HER2-Positive Breast Cancer

Among patients with previously treated HER2-positive metastatic breast cancer, those treated with pyrotinib plus ...

MARCH 9, 2022